Highlights Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Market Closed - Nasdaq Other stock markets 01:30:00 29/06/2024 am IST			5-day change	1st Jan Change
0.9475 ^USD	+0.80%		+4.30%	+72.27%

13/06	Xilio Therapeutics, Inc. Announces Board Appointments	CI
14/05	Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says	19/04	MT
Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02/04	CI
Xilio Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Sector Update: Health Care Stocks Slide Late Afternoon	02/04	MT
Top Midday Gainers	01/04	MT
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	01/04	MT
Top Premarket Gainers	01/04	MT
Xilio Shares Take Flight Premarket After Gilead Deal	28/03	DJ
Xilio Therapeutics Plans Private Placement, Job Cuts	28/03	DJ
Gilead Sciences in Exclusive License for Xilio Tumor-Activated IL-12 Program	28/03	DJ
Xilio Therapeutics, Inc. Enters Exclusive License Agreement with Gilead Sciences, Inc	28/03	CI
Xilio Therapeutics, Inc. Reports Additional Data from Its Phase 2 Clinical Trial Evaluating XTX202	28/03	CI
Xilio Therapeutics, Inc. Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101	07/12	CI
Xilio Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Xilio Therapeutics, Inc. Announces Initial Monotherapy Safety and Anti-Tumor Activity Data for XTX202	03/11	CI
Xilio Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Xilio Therapeutics, Inc. Announces Promotion of Chris Frankenfield to Chief Operating Officer	04/23/04	CI
Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/23/09	CI
Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	03/23/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Highlights

Filters